Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (233)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by WHITEHEAD, A.S.
Right arrow Articles by SCOTT, J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WHITEHEAD, A.S.
Right arrow Articles by SCOTT, J.M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 1995; 88: 763-766
© 1995 Association of Physicians

A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects

A.S. WHITEHEAD1, P. GALLAGHER1, J.L. MILLS2, P.N. KIRKE3, H. BURKE3, A.M. MOLLOY4, D.G. WEIR4, D.C. SHIELDS1 and J.M. SCOTT5,

1 Department of Genetics, and Biotechnology Institute Dublin, Ireland 2 National Institute of Child Health and Human Development Bethesda, USA 3 Health Research Board Dublin, Ireland 4 Department of Clinical Medicine Dublin, Ireland 5 Department of Biochemistry, Trinity College Dublin, Ireland

Address correspondence to Professor J.M. Scott, Department of Biochemistry, Trinity College, Dublin 2, Ireland

Received 10 August 1995 Accepted for publication 14 September 1995.


   Abstract

It is now well-established that folic acid, taken periconceptionally, can reduce the risk of neural tube defects (NTDs). Recent work has demonstrated that an abnormality of homocysteine metabolism is a critical factor. The gene for 5,10 methylenetetrahydrofolate reductase, an enzyme important in homocysteine metabolism, was studied in relation to NTDs. To determine the frequency of the allele for the thermolabile form of the reductase, DNA samples were collected from people with NTDs, parents of people with NTDs, and normal controls. Of 82 people with NTDs, 15 (18.3%) were homozygous for the abnormal, thermolabile allele. This was significantly higher (p=0.01) than the rate of 6.1% in the control population (odds ratio 3.47, 95% Cl 1.28–9.41). This is the first specific genetic abnormality to be identified in NTDs. It explains the association between some NTDs and elevated homocysteine, given that the reductase is important in homocysteine metabolism. It also explains how folic acid supplementation prevents some NTDs, by overcoming a partial block in the conversion of 5,10 methylenetetrahydrofolate to 5 methyltetrahydrofolate. Genetic screening could identify women who will require folic acid supplements to reduce their risk of having a child with an NTD.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
H. C Hamner, J. Mulinare, M. E Cogswell, A. L Flores, C. A Boyle, C. E Prue, C.-Y. Wang, A. L Carriquiry, and O. Devine
Predicted contribution of folic acid fortification of corn masa flour to the usual folic acid intake for the US population: National Health and Nutrition Examination Survey 2001-2004
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 305 - 315.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. E. Davidson, Q. Li, G. A. Churchill, L. R. Osborne, and H. E. McDermid
Modifier locus for exencephaly in Cecr2 mutant mice is syntenic to the 10q25.3 region associated with neural tube defects in humans
Physiol Genomics, October 19, 2007; 31(2): 244 - 251.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. M. van Beynum, L. Kapusta, M. den Heijer, S. H.H.M. Vermeulen, M. Kouwenberg, O. Daniels, and H. J. Blom
Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation
Eur. Heart J., April 2, 2006; 27(8): 981 - 987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R.-M. Gueant-Rodriguez, J.-L. Gueant, R. Debard, S. Thirion, L. X. Hong, J.-P. Bronowicki, F. Namour, N. W Chabi, A. Sanni, G. Anello, et al.
Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. E. Mitchell and C. R. Weinberg
Evaluation of Offspring and Maternal Genetic Effects on Disease Risk Using a Family-based Approach: The "Pent" Design
Am. J. Epidemiol., October 1, 2005; 162(7): 676 - 685.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Jugessur, A. J. Wilcox, R. T. Lie, J. C. Murray, J. A. Taylor, A. Ulvik, C. A. Drevon, H. A. Vindenes, and F. E. Abyholm
Exploring the Effects of Methylenetetrahydrofolate Reductase Gene Variants C677T and A1298C on the Risk of Orofacial Clefts in 261 Norwegian Case-Parent Triads
Am. J. Epidemiol., June 15, 2003; 157(12): 1083 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
L. Garcia-Fragoso, I. Garcia-Garcia, A. de la Vega, J. Renta, and C. L. Cadilla
Presence of the 5,10-Methylenetetrahydrofolate Reductase C677T Mutation in Puerto Rican Patients With Neural Tube Defects
J Child Neurol, January 1, 2002; 17(1): 30 - 32.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.